Trial Summary Domain from IG 3.1.2 to 3.1.3

14
Trial Summary Domain from IG 3.1.2 to 3.1.3 Dieter Boß September 2012

description

Trial Summary Domain from IG 3.1.2 to 3.1.3. Dieter Boß September 2012. Purpose of Trial Summary Domain. Submit summary of study in structured format Characteristics of trial, e.g., Protocol title Phase Randomization Primary and secondary objectives - PowerPoint PPT Presentation

Transcript of Trial Summary Domain from IG 3.1.2 to 3.1.3

Page 1: Trial Summary Domain  from IG 3.1.2 to 3.1.3

Trial Summary Domain from IG 3.1.2 to 3.1.3

Dieter Boß

September 2012

Page 2: Trial Summary Domain  from IG 3.1.2 to 3.1.3

2

Purpose of Trial Summary Domain

• Submit summary of study in structured format• Characteristics of trial, e.g.,

• Protocol title• Phase• Randomization• Primary and secondary objectives• Actual characteristics like number of subjects, data cut-off dates

• Information is provided in findings structure

20-Aug-12

Page 3: Trial Summary Domain  from IG 3.1.2 to 3.1.3

3

Trial Summary Specific Contents

• Standardized parameters – TSPARM • Listed in CDISC Controlled Terminology (CCT)• core concept: required, expected, permissible• Standard code lists or formats assigned to many parameters• Core concept reflects requirements for study protocol disclosure in

publicly available clinical trial registries like CT.GOV

• Values – TSVAL

• Null Flavor Values – TSNVAL• Since Trial Summary Update to 3.1.2• To provide standardized missing codes for not available required

parameters, e.g., “NA“

20-Aug-12

Page 4: Trial Summary Domain  from IG 3.1.2 to 3.1.3

4

Changes from 3.1.2

IG 3.1.2 TS Update IG 3.1.3 CCT

No of parameters

20 43 43 47

Required - 28 28 -

Conditionally Required (incl. If Applicable)

- 15 15 -

20-Aug-12

Page 5: Trial Summary Domain  from IG 3.1.2 to 3.1.3

5

Trial Summary Parameters in CCT

• CCT does not contain parameters• AGEU• DESIGN

• Does contain parameters• DOSE• DOSU• DOSFRQ• ROUTE

not listed any more in list of required or expected parameters

20-Aug-12

Page 6: Trial Summary Domain  from IG 3.1.2 to 3.1.3

6

Issues with Parameter List

• Information not always easily retrievable in study protocols•Company standards needed to make TS useful within company and for submissions•Code Lists are available for majority of parameters

Don‘t invent if available

• There are issues with a few special code lists

20-Aug-12

Page 7: Trial Summary Domain  from IG 3.1.2 to 3.1.3

7

Code List Issues

• SNOMED • Systemized Nomenclature of Medicine• Used for:• Trial Indication - INDIC • Diagnosis Group - TDIGRP

Not licenced in many companiesCan other dictionary or sponsor terms be used?

20-Aug-12

Page 8: Trial Summary Domain  from IG 3.1.2 to 3.1.3

8

Code List Issues

•NDF RT• National Drug File – Reference Terminology• Can be found via NCI website• Used for:• Pharmocological Class – PCLAS

Hard/ Impossible for data managers to identify correct term for products in development

20-Aug-12

Page 9: Trial Summary Domain  from IG 3.1.2 to 3.1.3

9

Code List Issues•UNII• Unique Ingredient Identifier• Connects to NCI Concept Code• Used for:• Investigational Therapy or Treatment – TRT

20-Aug-12

Page 10: Trial Summary Domain  from IG 3.1.2 to 3.1.3

10

Code List Issues

• SRS Preferred Substance Name• FDA Substance Registration System• Can be found via FDA website • Uses UNII codes and terms• Used for:• Comparative Treatment - COMPTRT• Current Treatment – CURTRT

Only available for approved substances ?

20-Aug-12

Page 11: Trial Summary Domain  from IG 3.1.2 to 3.1.3

11

UNII is Accessible via SRS

20-Aug-12

Page 12: Trial Summary Domain  from IG 3.1.2 to 3.1.3

12

Code List Issues

•DUNS• Dun and Bradstreet System to uniquely identify

companies• Recommeded by ISO• Used for:• Clinical Study Sponsor – SPONSOR

Unclear how to retrieve informationDownload ?

20-Aug-12

Page 13: Trial Summary Domain  from IG 3.1.2 to 3.1.3

13

Access to NDF-RT and UNII

20-Aug-12

Page 14: Trial Summary Domain  from IG 3.1.2 to 3.1.3

14

Thank You!

Questions?

20-Aug-12